Moreover, when cell viability was analyzed, results showed that combined inhibition of Trx and GSH led to the preferential killing of HIV‐1‐infected cells as compared to their uninfected counterparts (Fig EV5B), although specific leukemia/lymphoma cell lines were highly sensitive to AF and BSO treatment irrespective of HIV‐1 infection, in line with the previously described sensitivity of such neoplasias to these drugs (Fiskus et al, 2014; Benhar et al, 2016). The gene discussed is TXN; the disease is leukemia.